Skip to Content Facebook Feature Image

Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients

Business

Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients
Business

Business

Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients

2025-04-11 13:19 Last Updated At:13:35

SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin depressions, has successfully passed the review of the International Cosmetic Ingredient Nomenclature Committee ("INC") and been officially granted a standardized International Nomenclature Cosmetic Ingredient ("INCI") name under the designation "Exosome." This marks the first engineered exosome worldwide to receive an INCI designation, highlighting ImmVira's leadership in the field and a significant advancement in the development of next-generation cosmetic ingredients.

As a globally recognized regulatory standard, the INCI system has been widely adopted across major markets, including the U.S., EU, and China. The INCI system ensures reliable safeguards for transparency and consistency, which facilitates international regulatory compliance while enhancing consumer trust through ingredient labeling clarity and formulation safety.

Based on its OVPENS platform, ImmVira has developed a series of engineered exosome pipelines capable of simultaneous multi-protein delivery, targeting critical unmet medical needs in complex chronic and anti-aging related diseases. Compared to naturally derived exosomes, engineered exosomes offer advantages, including consistency and controllability in quality derived from stable cell lines, precise and stable therapeutic function benefiting from the precisely designed targeting functional proteins, and scalable GMP-standard manufacturing under strict supervision. The approval of MVR-EX103 by INCI is a significant milestone for the Company in advancing international partnerships and market expansion. ImmVira has entered a commercial partnership with a leading multinational corporation for the U.S. and Canadian markets of MVR-EX103. Meanwhile, more expansive global collaborative efforts are currently underway and progressing steadily.

Unlike conventional injectables, topical engineered exosome products designed for pan-dermatological applications benefit from a flexible and expedited registration pathway, enabling direct-to-market commercialization through the filing of cosmetic ingredients. Going forward, with the commitment to technology-driven development, ImmVira is poised to expand its engineered exosome applications across multiple sectors, driving the in-depth integration of both the healthcare and beauty industries. Through cutting-edge science and scalable solutions, ImmVira aims to deliver a new generation of safe, effective, and globally accessible cosmetic ingredients and skincare solutions.

About ImmVira

ImmVira is a global biotech company dedicated to developing breakthrough therapeutic solutions through efficient, safe, and targeted drug delivery technologies. The company centers its operations on the end-to-end drug development platform (OVPENS Platform) and has established an innovative R&D system that powers two robust delivery vectors: engineered oncolytic viruses and engineered exosomes. With an established CMC process in line with global standards, the platform originated multiple innovative drug candidates targeting major, complex, and refractory diseases, including cancer, respiratory diseases, metabolic disorders, neurodegenerative diseases, urological diseases, and dermatological conditions. Based on extensive research and development, ImmVira has pioneered, developed, and matured both the field of oncolytic viruses for cancer therapy and the field of engineered exosomes for non-cancer applications.

SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin depressions, has successfully passed the review of the International Cosmetic Ingredient Nomenclature Committee ("INC") and been officially granted a standardized International Nomenclature Cosmetic Ingredient ("INCI") name under the designation "Exosome." This marks the first engineered exosome worldwide to receive an INCI designation, highlighting ImmVira's leadership in the field and a significant advancement in the development of next-generation cosmetic ingredients.

As a globally recognized regulatory standard, the INCI system has been widely adopted across major markets, including the U.S., EU, and China. The INCI system ensures reliable safeguards for transparency and consistency, which facilitates international regulatory compliance while enhancing consumer trust through ingredient labeling clarity and formulation safety.

Based on its OVPENS platform, ImmVira has developed a series of engineered exosome pipelines capable of simultaneous multi-protein delivery, targeting critical unmet medical needs in complex chronic and anti-aging related diseases. Compared to naturally derived exosomes, engineered exosomes offer advantages, including consistency and controllability in quality derived from stable cell lines, precise and stable therapeutic function benefiting from the precisely designed targeting functional proteins, and scalable GMP-standard manufacturing under strict supervision. The approval of MVR-EX103 by INCI is a significant milestone for the Company in advancing international partnerships and market expansion. ImmVira has entered a commercial partnership with a leading multinational corporation for the U.S. and Canadian markets of MVR-EX103. Meanwhile, more expansive global collaborative efforts are currently underway and progressing steadily.

Unlike conventional injectables, topical engineered exosome products designed for pan-dermatological applications benefit from a flexible and expedited registration pathway, enabling direct-to-market commercialization through the filing of cosmetic ingredients. Going forward, with the commitment to technology-driven development, ImmVira is poised to expand its engineered exosome applications across multiple sectors, driving the in-depth integration of both the healthcare and beauty industries. Through cutting-edge science and scalable solutions, ImmVira aims to deliver a new generation of safe, effective, and globally accessible cosmetic ingredients and skincare solutions.

About ImmVira

ImmVira is a global biotech company dedicated to developing breakthrough therapeutic solutions through efficient, safe, and targeted drug delivery technologies. The company centers its operations on the end-to-end drug development platform (OVPENS Platform) and has established an innovative R&D system that powers two robust delivery vectors: engineered oncolytic viruses and engineered exosomes. With an established CMC process in line with global standards, the platform originated multiple innovative drug candidates targeting major, complex, and refractory diseases, including cancer, respiratory diseases, metabolic disorders, neurodegenerative diseases, urological diseases, and dermatological conditions. Based on extensive research and development, ImmVira has pioneered, developed, and matured both the field of oncolytic viruses for cancer therapy and the field of engineered exosomes for non-cancer applications.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients

Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients

HO CHI MINH CITY, Vietnam, Jan. 12, 2026 /PRNewswire/ -- Digital travel platform Agoda reveals that Vietnam is becoming an increasingly popular year-end travel choice for families in the region and beyond. Based on searches made between September and November 2025 for stays during December 2025 and January 2026, Agoda recorded a 30% increase in family travel interest to Vietnam compared with the same period the previous year.

Agoda data shows that Vietnam is attracting more international families than ever this winter holiday season. South Koreans take the lead as the top market interested in traveling to Vietnam in December and January, with families from India, Singapore, Australia, and Malaysia rounding out the top five. Notably, Agoda reported that Indian families showcased the highest growth in travel interest to Vietnam during this period, with a 186% increase in searches. Malaysians also, are expressing strong growth in interest, with a 74% increase in searches, highlighting Vietnam's appeal as a family destination in Southeast Asia and beyond.

Families are choosing Vietnam for its storied culture and cuisine, diverse landscapes, and abundance of family-friendly resorts and attractions.

Phu Quoc Island leads as the most sought-after destination among international family travelers with a 47% increase in searches, popular for its sandy beaches, calm waters, and nature parks ideal for multi-generation vacations. Da Nang follows with 42% growth in travel interest, noted for its beaches, soft adventure activities, and access to Ba Na Hills theme park. Nha Trang comes in third place, remaining a favorite for its long coastline, family-oriented resorts, and island experiences. In fourth place, Ho Chi Minh City appeals with its vibrant food scene, entertainment complexes, and day trips to the Mekong Delta. In the north, Hanoi continues to draw families with its cultural landmarks, museums, and festive atmosphere, rounding out the top five most family-friendly year-end destinations in Vietnam.

Meanwhile, although Vietnamese families traditionally travel less internationally at the end of the year – typically preferring to wait for the Lunar New Year - China is becoming a noticeable exception. Among the top 20 outbound destinations preferred by Vietnamese families during the December-January period, searches for Shanghai increased 58%, while Beijing increased 59%. This shift is supported by the launch of new direct routes between Hanoi and selected Chinese cities earlier this year, making end-of-year overseas trips more accessible than ever.

Vu Ngoc Lam, Country Director at Agoda, said: "It is wonderful to see Vietnam increasingly chosen as an end-of-year holiday destination for families from across Asia and beyond. Agoda's data shows that travelers are recognizing Vietnam's family-friendly appeal, which further strengthen its position on the global travel map. As more families plan their festive-season or year-end getaways, we are delighted to support them through Agoda's simple, intuitive platform and our wide range of stays, flights, and activities."

With over 6 million properties, 130,000 flight routes, and 300,000 activities, all bookable in one seamless itinerary, Agoda helps families plan memorable year-end holidays, whether they choose a peaceful beach break, a cultural city escape, or an international exploration to mark the close of the year.

HO CHI MINH CITY, Vietnam, Jan. 12, 2026 /PRNewswire/ -- Digital travel platform Agoda reveals that Vietnam is becoming an increasingly popular year-end travel choice for families in the region and beyond. Based on searches made between September and November 2025 for stays during December 2025 and January 2026, Agoda recorded a 30% increase in family travel interest to Vietnam compared with the same period the previous year.

Agoda data shows that Vietnam is attracting more international families than ever this winter holiday season. South Koreans take the lead as the top market interested in traveling to Vietnam in December and January, with families from India, Singapore, Australia, and Malaysia rounding out the top five. Notably, Agoda reported that Indian families showcased the highest growth in travel interest to Vietnam during this period, with a 186% increase in searches. Malaysians also, are expressing strong growth in interest, with a 74% increase in searches, highlighting Vietnam's appeal as a family destination in Southeast Asia and beyond.

Families are choosing Vietnam for its storied culture and cuisine, diverse landscapes, and abundance of family-friendly resorts and attractions.

Phu Quoc Island leads as the most sought-after destination among international family travelers with a 47% increase in searches, popular for its sandy beaches, calm waters, and nature parks ideal for multi-generation vacations. Da Nang follows with 42% growth in travel interest, noted for its beaches, soft adventure activities, and access to Ba Na Hills theme park. Nha Trang comes in third place, remaining a favorite for its long coastline, family-oriented resorts, and island experiences. In fourth place, Ho Chi Minh City appeals with its vibrant food scene, entertainment complexes, and day trips to the Mekong Delta. In the north, Hanoi continues to draw families with its cultural landmarks, museums, and festive atmosphere, rounding out the top five most family-friendly year-end destinations in Vietnam.

Meanwhile, although Vietnamese families traditionally travel less internationally at the end of the year – typically preferring to wait for the Lunar New Year - China is becoming a noticeable exception. Among the top 20 outbound destinations preferred by Vietnamese families during the December-January period, searches for Shanghai increased 58%, while Beijing increased 59%. This shift is supported by the launch of new direct routes between Hanoi and selected Chinese cities earlier this year, making end-of-year overseas trips more accessible than ever.

Vu Ngoc Lam, Country Director at Agoda, said: "It is wonderful to see Vietnam increasingly chosen as an end-of-year holiday destination for families from across Asia and beyond. Agoda's data shows that travelers are recognizing Vietnam's family-friendly appeal, which further strengthen its position on the global travel map. As more families plan their festive-season or year-end getaways, we are delighted to support them through Agoda's simple, intuitive platform and our wide range of stays, flights, and activities."

With over 6 million properties, 130,000 flight routes, and 300,000 activities, all bookable in one seamless itinerary, Agoda helps families plan memorable year-end holidays, whether they choose a peaceful beach break, a cultural city escape, or an international exploration to mark the close of the year.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Agoda Data Shows Vietnam Rising as a Favorite End-of-Year Destination for Families Across Asia and Beyond

Agoda Data Shows Vietnam Rising as a Favorite End-of-Year Destination for Families Across Asia and Beyond

Recommended Articles